Semma Therapeutics: Semma Therapeutics Announces Publication in Nature Demonstrating Advancements in Regenerative Cell Therapy for Type 1 Diabetes
Semma Therapeutics Inc. a biotechnology company pioneering the curative use of stem cells in regenerative medicine today announced the journal Nature published data demonstrating improvements in the production of beta cells cells th...
Read full article »
Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.
Read more